📰 Nasdaq Kala News
Nasdaq Kala News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Kala. Real-time updates on events, politics, business and more.
February 6, 2024
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) was up 0.1% during mid-day trading on Monday . The company traded as high as $7.10 and last traded at $6.97. Approximately 14,248 shares were traded during trading, a decline of 64% from the average daily volume of 39,852 shares. The stock had previously closed at $6.96. […]
January 6, 2024
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 4,539 shares of KALA BIO stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $6.73, for a total value of $30,547.47. Following the sale, the chief executive officer now directly owns 286,315 shares of […]
January 6, 2024
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 4,539 shares of KALA BIO stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $6.73, for a total value of $30,547.47. Following the completion of the sale, the chief executive officer now […]
December 3, 2023
Board of Trustees of The Leland Stanford Junior University raised its holdings in KALA BIO, Inc. (NASDAQ:KALA – Free Report) by 85.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,127 shares of the company’s stock after purchasing an additional 9,748 […]
October 16, 2023
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 100,000 shares, an increase of 48.4% from the September 15th total of 67,400 shares. Currently, 4.9% of the company’s stock are short sold. Based on an […]
September 14, 2023
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totalling 9,200 shares, a drop of 87.8% from the August 15th total of 75,500 shares. Approximately 0.5% of the company’s shares are short sold. Based on an […]
June 30, 2023
Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Free Report)’s share price was down 4.5% during mid-day trading on Thursday . The stock traded as low as $14.21 and last traded at $14.37. Approximately 68,731 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 693,209 shares. The stock had previously closed […]
June 8, 2023
Clear Street LLC acquired a new position in shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 49,390 shares of the company’s stock, valued at approximately $1,884,000. Kala Pharmaceuticals comprises about 0.0% of Clear Street […]
May 9, 2023
Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) shares shot up 3.1% during mid-day trading on Monday . The stock traded as high as $15.97 and last traded at $15.80. Approximately 78,700 shares traded hands during trading, a decline of 92% from the average daily volume of 937,802 shares. The stock had previously closed at $15.32. […]
April 12, 2023
Kala Pharmaceuticals (NASDAQ:KALA – Get Rating) had its price objective hoisted by investment analysts at HC Wainwright from $20.00 to $22.00 in a research note issued to investors on Wednesday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 28.58% from the company’s previous close. Kala Pharmaceuticals Stock Up 0.4 % […]